Show simple item record

dc.contributor.authorMills, S
dc.contributor.authorRadon, M
dc.contributor.authorRadon, M
dc.contributor.authorBaird, R
dc.contributor.authorHanemann, C
dc.contributor.authorKeatley, D
dc.contributor.authorLewis, J
dc.contributor.authorPollock, J
dc.contributor.authorSanghera, P
dc.contributor.authorThomas, S
dc.contributor.authorWhitfield, Gillian A
dc.contributor.authorRasheed, Z
dc.contributor.authorJenkinson, M
dc.date.accessioned2019-04-29T09:48:57Z
dc.date.available2019-04-29T09:48:57Z
dc.date.issued2019en
dc.identifier.citationMills SJ, Radon MR, Radon MR, Baird RD, Hanemann CO, Keatley D, et al. Utilization of volumetric magnetic resonance imaging for baseline and surveillance imaging in neuro-oncology. British J Radiol. 2019 Mar 29:20190059.en
dc.identifier.pmid30924680en
dc.identifier.doi10.1259/bjr.20190059en
dc.identifier.urihttp://hdl.handle.net/10541/621765
dc.description.abstractThe acquisition of volumetric post-contrast MRI has clear advantages in the interpretation of neuro-oncology studies but has yet to find its way into routine clinical practice beyond planning scans for surgery and radiotherapy. This commentary briefly highlights the benefits of these techniques whilst dispelling some of the perceived disadvantages.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1259/bjr.20190059en
dc.titleUtilization of volumetric magnetic resonance imaging for baseline and surveillance imaging in neuro-oncologyen
dc.typeArticleen
dc.contributor.departmentDepartment of Neuroradiology, National Cancer Research Institute Metastases and Meningioma subgroup of the Brain Clinical Studies Group and The Walton Centre NHS Foundation Trust , Liverpool , Englanden
dc.identifier.journalThe British Journal of Radiologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record